New radiation implant aims to control sarcoma with fewer side effects
NCT ID NCT04033081
First seen Apr 09, 2026 · Last updated May 25, 2026 · Updated 9 times
Summary
This study follows 100 sarcoma patients who receive a permanent radiation implant called CivaSheet during surgery. The implant delivers targeted radiation to kill remaining cancer cells. Researchers track safety, side effects, and tumor recurrence over 5 years. Participants must have sarcoma in the abdomen, pelvis, or trunk and be able to undergo surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
Conditions
Explore the condition pages connected to this study.